Jane Street’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Buy |
+54,910
| New | +$621K | ﹤0.01% | 3451 |
|
|
2025
Q1 | – | Sell |
-69,397
| Closed | -$588K | – | 6116 |
|
|
2024
Q4 | $588K | Buy |
69,397
+48,889
| +238% | +$414K | ﹤0.01% | 3721 |
|
|
2024
Q3 | $237K | Sell |
20,508
-16,505
| -45% | -$191K | ﹤0.01% | 5086 |
|
|
2024
Q2 | $436K | Sell |
37,013
-307,436
| -89% | -$3.62M | ﹤0.01% | 4655 |
|
|
2024
Q1 | $4.09M | Buy |
344,449
+306,932
| +818% | +$3.64M | ﹤0.01% | 1497 |
|
|
2023
Q4 | $460K | Buy |
37,517
+4,833
| +15% | +$59.2K | ﹤0.01% | 4198 |
|
|
2023
Q3 | $315K | Buy |
+32,684
| New | +$315K | ﹤0.01% | 4027 |
|
|
2023
Q1 | – | Sell |
-15,498
| Closed | -$105K | – | 5903 |
|
|
2022
Q4 | $105K | Buy |
+15,498
| New | +$105K | ﹤0.01% | 4668 |
|
|
2021
Q4 | – | Sell |
-19,797
| Closed | -$345K | – | 5657 |
|
|
2021
Q3 | $345K | Buy |
19,797
+7,618
| +63% | +$133K | ﹤0.01% | 3802 |
|
|
2021
Q2 | $292K | Buy |
+12,179
| New | +$292K | ﹤0.01% | 4010 |
|